Functional analysis of upstream common polymorphisms of the dopamine transporter gene

Schizophrenia Bulletin

Volumn 36, Issue 5, 2010, Pages 977-982

  Bamne, Mikhil N ^a   Talkowski, Michael E ^a,b   Chowdari, Kodavali V ^a   Nimgaonkar, Vishwajit L ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

bipolar disorder; dopamine transporter; electrophoretic mobility shift assay; reporter assay; schizophrenia; single nucleotide polymorphism

Indexed keywords

DOPAMINE TRANSPORTER; LUCIFERASE; TRANSCRIPTION FACTOR;

ALLELE; ARTICLE; ASSAY; BACTERIAL GENE; CELL LINE; COMPUTER MODEL; DNA FLANKING REGION; DNA POLYMORPHISM; DRUG BINDING; ELECTROPHORETIC MOBILITY; GEL MOBILITY SHIFT ASSAY; GENE FUNCTION; GENOMICS; HAPLOTYPE; HUMAN; MENTAL DISEASE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS;

ALLELES; CELL LINE, TUMOR; CHROMOSOMES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXONS; GENETIC VARIATION; HAPLOTYPES; HUMANS; NEUROBLASTOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SCHIZOPHRENIA; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE;

EID: 77955938172     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbp005     Document Type: Article

References (26)

1. Napolitano A, Cesura AM, Da Prada M. The role of mono-amine oxidase and catechol O-methyltransferase in dopami-nergic neurotransmission. J Neural Transm Suppl. 1995;45: 35-45.
2. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci. 1993;16:73-93.
3. Giros B, Caron MG. Molecular characterization of the dopa-mine transporter. Trends Pharmacol Sci. 1993;14:43-49.
4. Cragg SJ, Rice ME. Dancing past the DAT at a DA synapse. Trends Neurosci. 2004;27:270-277.
5. Giros B, el Mestikawy S, Godinot N, et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol. 1992;42: 383-390.
6. Vandenbergh DJ, Persico AM, Uhl GR. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res Mol Brain Res. 1992;15:161-166.
7. Bannon MJ, Michelhaugh SK, Wang J, Sacchetti P. The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur Neuropsychopharmacol. 2001;11:449-455.
8. Spencer TJ, Biederman J, Madras BK, et al. Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry. 2007;62:1059-1061.
9. Bannon MJ. The dopamine transporter: role in neurotoxicity and human disease. Toxicol Appl Pharmacol. 2005;204:355-360.
10. Talkowski ME, Kirov G, Bamne M, et al. A network of do-paminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet. 2008;17:747-758.
11. Wang J, Bannon MJ. Sp1 and Sp3 activate transcription of the human dopamine transporter gene. J Neurochem. 2005;93:474-482.
12. Kawarai T, Kawakami H, Yamamura Y, Nakamura S. Structure and organization of the gene encoding human dopamine transporter. Gene. 1997;195:11-18.
13. Fuke S, Sasagawa N, Ishiura S. Identification and characterization of the Hesr1/Hey1 as a candidate trans-acting factor on gene expression through the 3# non-coding polymorphic region of the human dopamine transporter (DAT1) gene. J Biochem. 2005;137:205-216.
14. Michelhaugh SK, Vaitkevicius H, Wang J, et al. Dopamine neurons express multiple isoforms of the nuclear receptor nurr1 with diminished transcriptional activity. J Neurochem. 2005;95:1342-1350.
15. Bannon MJ, Pruetz B, Manning-Bog AB, et al. Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proc Natl Acad Sci\USA. 2002;99:6382-6385.
16. Greenwood TA, Kelsoe JR. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics. 2003;82:511-520.
17. Lynch DR, Mozley PD, Sokol S, Maas NM, Balcer LJ, Siderowf AD. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Mov Disord. 2003;18:804-812.
18. Jacobsen LK, Staley JK, Zoghbi SS, et al. Prediction of dopa-mine transporter binding availability by genotype: a preliminary report. Am J Psychiatry. 2000;157:1700-1703.
19. van Dyck CH, Malison RT, Jacobsen LK, et al. Increased do-pamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med. 2005;46:745-751.
20. Drgon T, Lin Z, Wang GJ, et al. Common human 5' dopa-mine transporter (SLC6A3) haplotypes yield varying expression levels in vivo. Cell Mol Neurobiol. 2006;26:875-889.
21. Kelada SN, Costa-Mallen P, Checkoway H, et al. Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease. Pharmacogenet Genomics. 2005;15: 659-668.
22. Khodayari N, Garshasbi M, Fadai F, et al. Association of the dopamine transporter gene (DAT1) core promoter polymorphism\67T variant with schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2004;129:10-12.
23. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995;23:4878-4884.
24. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991;19: 2499.
25. Qiu P, Soder GJ, Sanfiorenzo VJ, et al. Quantification of single nucleotide polymorphisms by automated DNA sequencing. Biochem Biophys Res Commun. 2003;309:331-338.
26. Chen X, Wang X, Hossain S, et al. Haplotypes spanning SPEC2, PDZ-G EF2 and ACSL6 genes are associated with schizophrenia. Hum Mol Genet. 2006;15:3329-3342.